MakrisM, PapapostolouN, KoumprentziotisIA, et al.Nimesulide-induced fixed drug eruption followed by etoricoxib-induced fixed drug eruption: An unusual case report and review of the literature. J Clin Med. 2024; 13(6); doi: 10.3390/jcm13061583
2.
AndersonHJ, LeeJB. A review of fixed drug eruption with a special focus on generalized bullous fixed drug eruption. Medicina (Kaunas). 2021; 57(9); doi: 10.3390/medicina57090925
3.
BarbaudA, CastagnaJ, SoriaA. Skin tests in the work-up of cutaneous adverse drug reactions: A review and update. Contact Dermatitis. 2022; 86(5):344–356; doi: 10.1111/cod.14063
4.
Carneiro-LeãoL, Rodrigues CernadasJ. Bullous fixed drug eruption caused by etoricoxib confirmed by patch testing. J Allergy Clin Immunol Pract. 2019; 7(5):1629–1630; doi: 10.1016/j.jaip.2019.01.032
5.
PonceV, Muñoz-BellidoF, MorenoE, et al.Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib. Contact Dermatitis. 2012; 66(2):107–108; doi: 10.1111/j.1600-0536.2011.01982.x
